该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-30,Director,KAUFTHAL ILAN ,卖出,52315普通股, $54.32
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,EVP & COO,Cavanagh Shawn ,卖出,113749普通股, $50.00
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,EVP & COO,Cavanagh Shawn ,期权,113749普通股, $10.43
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,Director,KORB WILLIAM B ,卖出,10000普通股, $50.18
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,EVP & COO,Cavanagh Shawn ,卖出,113749普通股, $50.00
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,EVP & COO,Cavanagh Shawn ,期权,113749普通股, $10.43
$凯姆布雷克斯(CBM)$ 内部交易: 2015-11-18,Director,KORB WILLIAM B ,卖出,10000普通股, $50.18
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2015-11-05 AccNo: 0001437749-15-019827 Size: 39 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2015-11-03 AccNo: 0001437749-15-019421 Size: 476 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-03 AccNo: 0001437749-15-019417 Size: 5 MB 网页链接